Featured Research

from universities, journals, and other organizations

Potential New Treatment Approach For Severe Asthma

Date:
September 15, 2005
Source:
BMJ Specialty Journals
Summary:
Researchers have uncovered a potentially new treatment approach for severe asthma, by blocking a powerful immune system chemical, present in large amounts in patients with the severe form of the disease, a small study in Thorax reveals.

Researchers have uncovered a potentially new treatment approach forsevere asthma, by blocking a powerful immune system chemical, presentin large amounts in patients with the severe form of the disease, asmall study in Thorax reveals.

Related Articles


Around one in 10 asthmatics has the severe form of the disease,which frequently requires progressively higher doses of steroids in abid to control symptoms.

Severe asthma is also associated with a much higher risk of illness anddeath than milder forms and accounts for almost a third of healthservice costs for asthma

The research team investigated tumour necrosis factor alpha (TNFalpha), which is found in a range of chronic inflammatory conditions,including rheumatoid arthritis, Crohn's disease, and psoriasis.

Included in the study were 26 healthy people, 67 mild asthmatics, and 51 severe asthmatics.Bronchial fluid and lung tissue samples were taken from the participants to discover their levels of TNF alpha.

Levels were significantly higher in those with severe disease and concentrated in one particular type of immune cell(mast cells) which are recognised components of the inflammatory reaction in asthma.

TNF alpha levels were low and similar in those with no asthma or who only had mild symptoms.

This suggests that the high levels of TNF alpha in severe disease arecharacteristic of more chronic disease that is resistant to steroidtreatment, rather than a feature of the disease itself, say theauthors.

Seventeen people with severe asthma who still had symptoms, despitebeing treated with a range of drugs, were also given 25 mg of a drugthat blocks TNF alpha production (etanercept) twice weekly, injectedbelow the skin for 12 weeks. Fifteen completed the course.

At the end of the study period, these patients experienced asignificant improvement in symptoms and lung function. Two patientswere able to discontinue one of their drugs.

The treatment also curbed the inflammatory reaction in the lungs, knownas bronchial hyperresponsiveness. And there were few side effects.

The authors caution that further research will be required before thisapproach can be recommended, but they say that it offers a potentiallynew avenue of treatment for severe asthma.


Story Source:

The above story is based on materials provided by BMJ Specialty Journals. Note: Materials may be edited for content and length.


Cite This Page:

BMJ Specialty Journals. "Potential New Treatment Approach For Severe Asthma." ScienceDaily. ScienceDaily, 15 September 2005. <www.sciencedaily.com/releases/2005/09/050915010510.htm>.
BMJ Specialty Journals. (2005, September 15). Potential New Treatment Approach For Severe Asthma. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2005/09/050915010510.htm
BMJ Specialty Journals. "Potential New Treatment Approach For Severe Asthma." ScienceDaily. www.sciencedaily.com/releases/2005/09/050915010510.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins